Agilon Health, Inc.
NYSE:AGL · New York Stock Exchange
+$2.26 today
Vol 0.24M · Avg 0.41M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-319.8%
avg -45.6%
ROIC
-196.7%
avg -56.9%
ROA
-31.9%
avg -25.4%
Analysis
ROA is currently the strongest return metric at -31.9% versus its period average of -25.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jeffrey Alan Schwaneke | Executive Vice President & Chief Financial Officer | $910,875.00 | — | 50 | $140,342.00 | 0.84% |
Benjamin Shaker | Chief Markets Officer | $657,545.00 | — | 43 | $122,850.00 | 0.74% |
Denise Zamore | Chief Legal Officer & Secretary | $623,408.00 | — | 51 | $66,112.00 | 0.40% |
Girish Venkatachaliah | Chief Technology Officer | $618,579.00 | — | 52 | $38,236.00 | 0.23% |
Evan Smith | Senior Vice President of Investor Relations | — | — | — | $4,126.00 | 0.02% |
Kenny Bellendir | Markets Chief Financial Officer | — | — | — | — | — |
Timothy Gertsch | Chief Accounting Officer | — | — | 39 | $14,169.00 | 0.08% |
Timothy Patrick O'Rourke | CEO & Director | — | — | — | $14,169.00 | 0.08% |
Heidi Hittner | Chief Business Operations Officer | — | — | — | — | — |
Leland Thomas | Senior Manager of Investor Relations | — | — | — | $24,014.41 | 0.14% |
Ronald Allan Williams | Executive Chairman | — | — | 77 | $149,141.00 | 0.89% |
Bill Farry | Chief of Technology Innovation | — | — | — | — | — |
Karthik Rao | Chief Medical Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$351,990.90
Sells
0
$0.00
Net Sentiment
+$351,990.90
Net buying
Most Active
Shaker Benjamin
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Shaker Benjamin Direct | Buy | 500.0K | $0.60 | $301,050.00 | |
| Nov 12, 2025 | Wulf John William Direct | Buy | 81.0K | $0.63 | $50,940.90 |
Analysis
Insiders reported 2 buys worth $351,990.90 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $351,990.90. Shaker Benjamin was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A5 analysts |
| Revenue | N/A | N/A | +52.4% | +10.4% (7yr)7 analysts |
| Net Income | N/A | N/A | N/A | N/A7 analysts |
| EBIT | N/A | N/A | N/A | N/A7 analysts |
Analysis
Recent growth has been strongest in Revenue at +52.4% over three years. Forward estimates point to Revenue at +10.4% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Enhabit, Inc.
EHAB
$706.91M
Annexon, Inc.
NASDAQ:ANNX
$579.44M
Charming Medical Limited Class A Ordinary Shares
MCTA
$445.55M
DBV Technologies S.A.
NASDAQ:DBVT
$383.94M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$379.49M
Simulations Plus, Inc.
NASDAQ:SLP
$368.85M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$302.16M
enGene Holdings Inc.
NASDAQ:ENGN
$88.82M
Definitive Healthcare Corp.
NASDAQ:DH
$84.97M
Nakamoto Inc.
NASDAQ:NAKA
$74.66M
Who manages AGL?
Agilon Health, Inc. (AGL) lists 13 active executives. The top listed executive is Evan Smith, Senior Vice President of Investor Relations.
Are AGL insiders buying or selling?
Recent insider activity shows net selling of $1.94B.
Explore More
Continue the stock analysis
Jump to another research area for this company.